Van Cleave J, Gortmaker SL, Perrin JM. Dynamics of obesity and chronic health conditions among children and youth. JAMA. 2010;303(7):623–30.
Centers for Disease Control and Prevention. 2014 National Health Interview Survey (NHIS) Data. Table 3-1, current asthma population estimates—in thousands by age, United States. https://www.cdc.gov/asthma/nhis/2014/table3-1.htm. Accessed June 2017.
Schmier JK, Manjunath R, Halpern MT, et al. The impact of inadequately controlled asthma in urban children on quality of life and productivity. Ann Allergy Asthma Immunol. 2007;98(3):245–51.
Raissy HH, Kelly HW. Inhaled corticosteroids: the last 5 years. Clin Investig. 2013;3(6):595–602.
National Institutes of Health; National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Full Report of the Expert Panel: Guidelines for the diagnosis and management of asthma (EPR-3) 2007. https://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines/full-report. Accessed June 2017.
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2017. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed Aug 2017.
Kew KM, Dahri K. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Cochrane Database Syst Rev. 2016;1:CD011721.
Anderson DE, Kew KM, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Cochrane Database Syst Rev. 2015;8:CD011397. doi:10.1002/14651858.CD011397.pub2.
Evans DJ, Kew KM, Anderson DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Cochrane Database Syst Rev. 2015;7:CD011437. doi:10.1002/14651858.CD011437.pub2.
Kew KM, Evans DJ, Allison DE, Boyter AC. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma. Cochrane Database Syst Rev. 2015;6:CD011438. doi:10.1002/14651858.CD011438.pub2.
SPIRIVA® RESPIMAT® (tiotropium bromide) inhalation spray, for oral inhalation [prescribing information]. Ridgefield: Boehringer Ingelheim Pharmaceuticals, Inc.; 2017. http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Spiriva%20Respimat/spirivarespimat.pdf. Accessed June 2017.
Belmonte KE. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:297–304.
Radovanovic D, Santus P, Blasi F, Mantero M. Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside. Multidiscip Respir Med. 2017;12:17. doi:10.1186/s40248-017-0099-y.
Vogelberg C, Moroni-Zentgraf P, Leonaviciute-klimantaviciene M, et al. A randomized dose-ranging study of tiotropium respimat in children with symptomatic asthma despite inhaled corticosteroids. Resp Res. 2015;16:20.
Szefler SJ, Murphy K, Harper T, et al. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma. J Allergy Clin Immunol. 2017;. doi:10.1016/j.jaci.2017.01.014
(Epub 9 Feb 2017).
Vogelberg C, Engel M, Moroni-Zentgraf P, et al. Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomized dose-ranging study. Respir Med. 2014;108(9):1268–76.
Hamelmann E, Bateman ED, Vogelberg C, et al. Tiotropium add-on therapy in adolescent with moderate asthma: a 1 year randomized controlled trial. J Allergy Clin Immunol. 2016;138(2):441.e8–450.e8.
Hamelmann E, Bernstein JA, Vandewalker M, et al. A randomized controlled trial of tiotropium in adolescents with severe symptomatic asthma. Eur Respir J. 2017;49(1).
Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children. Cochrane Database Syst Rev. 2015;11:CD007949.
Stempel DA, Szefler SJ, Pedersen S, VESTRI Investigators, et al. Safety of adding salmeterol to fluticasone propionate in children with asthma. N Engl J Med. 2016;375:840–9.
Lemanske RF Jr, Mauger DT, Sorkness CA, Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975–85.